Ironwood Pharmaceuticals | IRWD - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.6M 160K 2026-03
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 340M 144M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Coherus Biosciences USD 2.25M 76K 2025-12
Halozyme Therapeutics USD 5.59M 80K 2026-06
Incyte USD 582K 13K 2026-06
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
MacroGenics USD 4.89M 1.55M 2026-03
Moderna USD 10.96B 527M 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
Pacira USD 3.62M 77K 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Takeda JPY 63.85B 20.2B 2026-06
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12